NCT07715500

Brief Summary

Living donor liver transplantation is widely accepted as an life-saving treatment for patients with end-stage liver diseases. Careful donor selection is essential to maximize the success and minimize the risk of postoperative complications in donors and recipients. Mapping of biliary anatomy is one of the critical assessments for donor selection and surgical planning ,Biliary reconstruction is considered as the "Achilles heel" of liver transplantation and adequate imaging assessment of biliary anatomy can largely benefit the biliary anastomosis. Preoperative imaging assessment of biliary anatomy is good for the selection of donors but may not indispensable for surgical planning and Intraoperative confirmative assessment of biliary anatomy with IOC was essential

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
1mo left

Started Jul 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress94%
Jul 2025Aug 2026

Study Start

First participant enrolled

July 1, 2025

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

January 1, 2026

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 15, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 20, 2026

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2026

Expected
Last Updated

July 20, 2026

Status Verified

January 1, 2026

Enrollment Period

1 year

First QC Date

January 1, 2026

Last Update Submit

July 16, 2026

Conditions

Keywords

Liver TransplantationMagnetic Resonance CholangiopancreatographyLiver donors

Outcome Measures

Primary Outcomes (1)

  • To identify factors causing early biliary complications like type and number of arterial & biliary reconstruction, type of graft, number & size of Bile ducts in donor in both groups

    6 month of postop

Secondary Outcomes (2)

  • Donor biliary complications in both group

    1 month of postoperative period

  • Identify Risk factors for early Biliary complications in recipients

    till 6 months of Post operative period of Liver transplant

Study Arms (2)

No MRCP GROUP

NO INTERVENTION

Magnetic Resonance Cholangiopancreatography is not done as part of Routine Liver donor workup

MRCP GROUP

EXPERIMENTAL

Magnetic Resonance Cholangiopancreatography is done as part of Routine Liver donor workup

Diagnostic Test: Magnetic Resonance Cholangiopancreatography

Interventions

Magnetic Resonance Cholangiopancreatography is being excluded from list of Investigation as part of Non inferiority trial

MRCP GROUP

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • All prospective voluntary healthy liver donor of age 18-55

You may not qualify if:

  • Type C/D Portal vein anatomy
  • Left sided Gallbladder
  • Right Posterior Graft
  • Recipients undergoing Hepaticojejunostomy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

ILBS

New Delhi, 110070, India

RECRUITING

MeSH Terms

Conditions

Fibrosis

Interventions

Cholangiopancreatography, Magnetic Resonance

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Magnetic Resonance ImagingTomographyDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisDiagnostic Techniques, Digestive System

Central Study Contacts

Dr Atul Renjit, MBBS, MS, DNB

CONTACT

Dr Nilesh Sadashiv Patil, MCH

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 1, 2026

First Posted

July 20, 2026

Study Start

July 1, 2025

Primary Completion

July 15, 2026

Study Completion (Estimated)

August 30, 2026

Last Updated

July 20, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations